MeiraGTx Holdings plc (MGTX) shares dropped 12.89% to $9.80, down $1.45 on Thursday over the company's newly announced equity offering, and a strategic asset acquisition.
The stock is currently trading at $9.80, below its previous close of $11.25 on the Nasdaq. It opened at $9.55 and has traded in a range of $8.77 to $10.05 during the session, with volume reaching 838,979 shares compared to an average of 503,356 shares.
The company announced it will acquire full rights to bota-vec from Johnson & Johnson for the treatment of X-linked retinitis pigmentosa, while also pricing an offering of 11.1 million shares at $9.00 per share to raise approximately $100 million.
The 52-week range for the stock is $4.55 to $11.85.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.